Clinical Trial Update: Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effects of sublingual sufentanil 30 µg on postoperative recovery in knee arthroscopy; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Arthroscopy
• Knee Conditions

Drugs mentioned

• sublingual sufentanil 30 µg (sufentanil)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Knee Arthroscopy | Phase 4 | Status: TERMINATED | Results posted: 2023-12-13